Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin‐Centered Interventions
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Diala Haykal. Beteiligte Einrichtung: Centre Médical Laser Palaiseau, Private Practice, Palaiseau, France. Hauptthemen laut MEDLINE: Aging, Dermatology, Geroscience, Longevity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Longevity medicine is an emerging clinical framework aimed at extending healthspan by targeting the biological mechanisms of aging rather than treating disease in isolation. Geroscience, which investigates the molecular and cellular pathways linking aging to chronic pathology, provides the scientific foundation for this approach. Dermatology is uniquely positioned within this paradigm, as the skin represents both a visible marker of biological aging and an accessible source of biomarkers.
Objective
To explore how principles of geroscience can be translated into clinical dermatology and cosmetic practice, with a focus on skin‐centered biomarkers, artificial intelligence (AI), and preventive longevity‐oriented interventions.
Methods
This piece integrates current evidence from geroscience, dermatologic aging research, microbiome science, and AI‐driven analytics to examine emerging models of longevity‐focused dermatologic care. Conceptual frameworks, clinical readiness of interventions, and ethical considerations are critically discussed.
Results
Advances in biological aging biomarkers, including epigenetic clocks, inflammatory signatures, mitochondrial and metabolic markers, and skin microbiome profiling, offer promising tools for assessing cutaneous and systemic aging. AI‐enabled platforms facilitate the integration of multidimensional data, enabling refined biological age assessment and potential prediction of treatment responses. However, most longevity‐oriented diagnostics and interventions remain in early or experimental stages, requiring rigorous validation before routine clinical adoption.
Conclusion
Dermatology can serve as a translational bridge between geroscience and clinical longevity medicine by integrating validated skin biomarkers, aesthetic procedures, and preventive strategies within an evidence‐based framework. Careful attention to scientific limitations, ethical considerations, and health equity is essential to ensure responsible implementation. Dermatologists would play a key role in shaping clinically sound, prevention‐focused longevity care centered on long‐term skin health and resilience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre Médical Laser Palaiseau, Private Practice, Palaiseau, France.
ORCID-Profile: Diala Haykal
Zitieren
APA
Haykal, D. (2026). Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin‐Centered Interventions. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70616
Vancouver
Haykal D. Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin‐Centered Interventions. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70616
BibTeX
@article{Haykal2026,
author = {Haykal, Diala},
title = {Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin‐Centered Interventions},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70616}
}
EUVIMED